All Systems

NextSeq 550 System

Seamless transition from array scanning to sequencing

Perform next-generation sequencing (NGS) and cytogenomic microarray scanning all on one research instrument. The NextSeq 550 System combines high-quality array scanning with the proven and robust NextSeq 500 sequencing system. By leveraging array scanning on the NextSeq 550 System, researchers have instant access to a powerful, complementary technology to confirm copy number variants detected through sequencing.

Download Data Sheet

Next: Same sequencing power as the NextSeq 500 System

Same high-quality, flexible sequencing power as the NextSeq 500 System

The NextSeq Series provides the flexible power and simplicity you need for transcriptome and targeted resequencing. With tunable output and exceptional data quality, the NextSeq Series offers a combination of high-throughput sequencing, flexibility, and accuracy, all at a cost that makes it just right for your lab.

Learn More

Next: Supports cytogenomic and karyomapping applications

Supports cytogenomic and karyomapping applications

The NextSeq 550 maximizes the menu of cutting-edge research applications, while minimizing instrument costs. The flexibility of the NextSeq 550 System enables a broad range of cytogenetics applications for reproductive, genetic health, and cancer research. Supported cytogenomic and karyomapping array products include:

Next: Cytogenomic data analysis software

Cytogenomic data analysis software

BlueFuse Multi software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework. It offers a clear, intuitive user interface; a common workflow; and scales for the needs of your lab. This widely implemented software is used in over 150 clinical research laboratories globally and for more than 80% of the PGS cycles currently being screened.

Learn More

Start Over: Seamless transition from array scanning to sequencing
  1.  
  2.  
  3.  
  4.  

Workflow

 
Method:

Cytogenomic arrays for chromosomal abnormalities

 
Array Scanning

High-quality array scanning and sequencing in one instrument, the NextSeq 550 System

 
Data Analysis

BlueFuse Multi Software for cytogenomic data analysis

See NextSeq Sequencing Workflows

NextSeq 550 System Array Scanning Parameters

40 min

per Beadchip

Infinium CytoSNP-850K BeadChip
HumanCytoSNP-12 BeadChip
HumanKaryomap-12 BeadChip

5 min

per Sample

Infinium CytoSNP-850K BeadChip

3.3 min

per Sample

HumanCytoSNP-12 BeadChip
HumanKaryomap-12 BeadChip

View NextSeq Series Sequencing Specifications
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.

Featured Products

HumanCytoSNP-12 BeadChip
HumanCytoSNP-12 BeadChip

This 12-sample array allows analysis of genetic and structural variation in the human genome, such as duplications, deletions, amplifications, copy-neutral LOH, and mosaicism.

Infinium CytoSNP-850K v1.3 BeadChip
Infinium CytoSNP-850K v1.3 BeadChip

This consortium-built array provides comprehensive coverage of cytogenetically relevant genes for congenital disorders and cancer research.

HumanKaryomap-12 DNA Analysis Kit
HumanKaryomap-12 DNA Analysis Kit

This genome-wide karyomapping microarray provides insight into the inheritance of single-gene defects by testing single cells from embryo biopsies.

View All NextSeq 550 Products

Related Solutions

For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.